Asano T - Search Results

1

Antivasospastic Effects of Hydroxyfasudil, a Rho-Kinase Inhibitor, After Subarachnoid Hemorrhage.

Satoh SI, Takayasu M, Kawasaki K, Ikegaki I, Hitomi A, Yano K, Shibuya M, Asano T. Satoh SI, et al. Among authors: asano t. J Pharmacol Sci. 2012;118(1):92-98. doi: 10.1254/jphs.11075FP. Epub 2019 Jun 11. J Pharmacol Sci. 2012. PMID: 32092842 Free article.

2

Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage.

Satoh S, Takayasu M, Kawasaki K, Ikegaki I, Hitomi A, Yano K, Shibuya M, Asano T. Satoh S, et al. Among authors: asano t. J Pharmacol Sci. 2012;118(1):92-8. doi: 10.1254/jphs.11075fp. Epub 2011 Dec 21. J Pharmacol Sci. 2012. PMID: 22186620 Free article.

3

Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: a review of preclinical and clinical studies.

Satoh S, Ikegaki I, Kawasaki K, Asano T, Shibuya M. Satoh S, et al. Among authors: asano t. Curr Vasc Pharmacol. 2014;12(5):758-65. doi: 10.2174/1570161112666140613115813. Curr Vasc Pharmacol. 2014. PMID: 24923440 Review.

4

Effects of Rho-kinase inhibitor on vasopressin-induced chronic myocardial damage in rats.

Satoh Si, Ikegaki I, Toshima Y, Watanabe A, Asano T, Shimokawa H. Satoh Si, et al. Among authors: asano t. Life Sci. 2002 Nov 22;72(1):103-12. doi: 10.1016/s0024-3205(02)02178-1. Life Sci. 2002. PMID: 12409149

5

Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction.

Satoh S, Yamaguchi T, Hitomi A, Sato N, Shiraiwa K, Ikegaki I, Asano T, Shimokawa H. Satoh S, et al. Among authors: asano t. Eur J Pharmacol. 2002 Nov 29;455(2-3):169-74. doi: 10.1016/s0014-2999(02)02619-5. Eur J Pharmacol. 2002. PMID: 12445583

6

Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal death in gerbils.

Satoh S, Toshima Y, Ikegaki I, Iwasaki M, Asano T. Satoh S, et al. Among authors: asano t. Brain Res. 2007 Jan 12;1128(1):175-80. doi: 10.1016/j.brainres.2006.10.027. Epub 2006 Nov 22. Brain Res. 2007. PMID: 17123488

7

Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model.

Satoh S, Toshima Y, Hitomi A, Ikegaki I, Seto M, Asano T. Satoh S, et al. Among authors: asano t. Brain Res. 2008 Feb 8;1193:102-8. doi: 10.1016/j.brainres.2007.11.050. Epub 2007 Dec 4. Brain Res. 2008. PMID: 18187127

8

Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction.

Yano K, Kawasaki K, Hattori T, Tawara S, Toshima Y, Ikegaki I, Sasaki Y, Satoh S, Asano T, Seto M. Yano K, et al. Among authors: asano t. Eur J Pharmacol. 2008 Oct 10;594(1-3):77-83. doi: 10.1016/j.ejphar.2008.07.045. Epub 2008 Jul 31. Eur J Pharmacol. 2008. PMID: 18703046

9

Correspondence between neurological deficit, cerebral infarct size, and Rho-kinase activity in a rat cerebral thrombosis model.

Kawasaki K, Yano K, Sasaki K, Tawara S, Ikegaki I, Satoh S, Ohtsuka Y, Yoshino Y, Kuriyama H, Asano T, Seto M. Kawasaki K, et al. Among authors: asano t. J Mol Neurosci. 2009 Sep;39(1-2):59-68. doi: 10.1007/s12031-009-9175-x. Epub 2009 Jan 23. J Mol Neurosci. 2009. PMID: 19165632

10

Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage.

Satoh S, Hitomi A, Ikegaki I, Kawasaki K, Nakazono O, Iwasaki M, Mohri M, Asano T. Satoh S, et al. Among authors: asano t. Brain Res Bull. 2010 Jan 15;81(1):191-5. doi: 10.1016/j.brainresbull.2009.08.021. Brain Res Bull. 2010. PMID: 19723568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,964 results

Search Page

Filters